Eleanor Pope, B., Eric Kowalski, M., & Francisco Tausk, M. (2022). Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis. Elsevier.
Chicago Style (17th ed.) CitationEleanor Pope, BA, MD Eric Kowalski, and MD Francisco Tausk. Topical Ruxolitinib in the Treatment of Refractory Facial Seborrheic Dermatitis. Elsevier, 2022.
MLA (9th ed.) CitationEleanor Pope, BA, et al. Topical Ruxolitinib in the Treatment of Refractory Facial Seborrheic Dermatitis. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.